Schering-Plough’s Nasonex is an intranasal steroid that significantly improves nasal allergy symptoms when taken once each day. Nasonex is said to be the first intranasal steroid to be approved in Japan for once-daily administration.
Nasonex is currently approved in over 100 countries worldwide and is anticipated to be available in Japan in 2008 fall.
Robert Spiegel, chief medical officer of Schering-Plough Research Institute, said: “Nasonex provides physicians with an important treatment option for the relief of nasal allergy symptoms, especially for those patients looking for the convenience of a once-daily treatment.”